![](https://www.eversana.com/wp-content/uploads/2024/06/SM-2Q2024-POV-European-Parliment_IB-Insight-FG-300x200.png)
Posted on June 28, 20246/28/24
European Parliament’s Revision of the General Pharmaceutical Legislation
![](https://www.eversana.com/wp-content/uploads/2019/08/Insights_Pg_Webinar.png)
Posted on June 28, 20246/28/24
Strategic Launch: Accelerating Innovative Therapies in the Chinese Market
![](https://www.eversana.com/wp-content/uploads/2024/06/market-access-IRA-03-300x200.png)
Posted on June 24, 20246/24/24
Market Access and the Inflation Reduction Act
![](https://www.eversana.com/wp-content/uploads/2024/06/IDN_POV_IB-300x200.png)
Posted on June 21, 20246/21/24
Optimizing Product Commercialization in Today’s IDN Environment
![](https://www.eversana.com/wp-content/uploads/2020/07/Webinar_600x400_web_graphic.png)
Posted on May 31, 20245/31/24
M&A and BD&L Outlook and Perspectives on Commercial Due Diligence
![](https://www.eversana.com/wp-content/uploads/2024/05/IB_Insight_Redefining-Field-Deployment-300x200.png)
Posted on May 23, 20245/23/24
Bridging “Share of Voice” with “Share of Influence” for Lasting Impact
![](https://www.eversana.com/wp-content/uploads/2024/05/IB_Insight_Driving-Change-in-Drug-Access-300x200.png)
Posted on May 23, 20245/23/24
IDNs: Driving Change in Drug Access and Utilization
![V&E New Leaders 2024 EVERSANA HEOR](https://www.eversana.com/wp-content/uploads/2024/03/FG_VE-New-Leaders_EVERSANA-300x200.png)
Posted on March 27, 20243/27/24
Growing EVERSANA’s Value & Evidence Global Footprint with the Additions of Monique Martin, Pamela Vo and Deepika Thakur
![](https://www.eversana.com/wp-content/uploads/2024/03/IB_Insight_Image-1-300x200.png)
Posted on March 12, 20243/12/24
Evolving Dynamics in Oncology: Considerations for Overcoming Commercialization Challenges and Driving Greater Impact
![](https://www.eversana.com/wp-content/uploads/2024/02/POV_1Q24_Innovation_EVERSANA_IB-Insight-FG-300x200.png)
Posted on March 1, 20243/1/24